GREAT POINT PARTNERS LLC - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 90 filers reported holding HERON THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is 0.04 and the average weighting 0.8%.

Quarter-by-quarter ownership
GREAT POINT PARTNERS LLC ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$4,879,489
-11.2%
4,737,3680.0%0.89%
-17.4%
Q2 2023$5,495,347
-37.4%
4,737,368
-18.6%
1.08%
-37.6%
Q1 2023$8,784,226
-44.8%
5,817,368
-8.5%
1.72%
-44.7%
Q4 2022$15,900,403
-32.3%
6,360,161
+12.7%
3.12%
-44.9%
Q3 2022$23,484,000
+497.7%
5,645,161
+1990.8%
5.66%
+227.1%
Q1 2015$3,929,000270,0001.73%
Other shareholders
HERON THERAPEUTICS INC shareholders Q2 2015
NameSharesValueWeighting ↓
TANG KEVIN C 760$783100.00%
Velan Capital Investment Management LP 6,986,744$7,196,3465.80%
Tejara Capital Ltd 2,109,681$2,172,9711.23%
JW Asset Management, LLC 2,407,418$2,479,6411.07%
Rubric Capital Management LP 26,713,503$27,514,9081.03%
GREAT POINT PARTNERS LLC 4,737,368$4,879,4890.89%
Orchard Capital Management, LLC 2,142,823$2,207,1080.82%
Clearline Capital LP 6,149,842$6,334,3380.54%
CM Management, LLC 450,000$463,5000.49%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 327,450$337,2740.48%
View complete list of HERON THERAPEUTICS INC shareholders